A proteomic approach to identify candidate substrates of human adenovirus E4orf6-E1B55K and other viral cullin-based E3 ubiquitin ligases

Journal of Virology

Volumn 83, Issue 23, 2009, Pages 12172-12184

  Dallaire, Frédéric ^a   Blanchette, Paola ^a   Branton, Philip E ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; ALPHA3 INTEGRIN; CELL PROTEIN; CORTACTIN; CORTACTIN REPEAT 2; CULLIN; DYNACTIN; DYNEIN ADENOSINE TRIPHOSPHATASE; ELONGIN B; ELONGIN C; LAMIN; LAMIN B2; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE KINASE 2; MRE11 PROTEIN; PROTEIN E1B55K; PROTEIN E4ORF6; PROTEIN P53; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; ENZYME SUBSTRATE COMPLEX; HUMAN; HUMAN ADENOVIRUS; HUMAN ADENOVIRUS 5; HUMAN CELL; MASS SPECTROMETRY; MOLECULAR RECOGNITION; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEOMICS; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ADENOVIRUS E1 PROTEINS; ADENOVIRUS E4 PROTEINS; ADENOVIRUSES, HUMAN; CELL LINE, TUMOR; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; HOST-PATHOGEN INTERACTIONS; HUMANS; INTEGRIN ALPHA3; MASS SPECTROMETRY; PROTEOMICS; SUBSTRATE SPECIFICITY; UBIQUITIN-PROTEIN LIGASES;

ADENOVIRIDAE; HUMAN ADENOVIRUS;

EID: 70450202860     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.01169-09     Document Type: Article

References (84)

1. Ammer, A. G., and S. A. Weed. 2008. Cortactin branches out: roles in regulating protrusive actin dynamics. Cell Motil. Cytoskeleton. 65:687-707.
2. Babiss, L. E., and H. S. Ginsberg. 1984. Adenovirus type 5 early region 1b gene product is required for efficient shutoff of host protein synthesis. J. Virol. 50:202-212.
3. Baker, A., K. J. Rohleder, L. A. Hanakahi, and G. Ketner. 2007. Adenovirus E4 34K and E1B 55K oncoproteins target host DNA ligase IV for proteasomal degradation. J. Virol. 81:7034-7040. (Pubitemid 46986639)
4. Barry, M., and K. Fruh. 2006. Viral modulators of cullin RING ubiquitin ligases: culling the host defense. Sci. STKE 2006:pe21.
5. Beckmann, R., K. Buchner, P. R. Jungblut, C. Eckerskorn, C. Weise, R. Hilbert, and F. Hucho. 1992. Nuclear substrates of protein kinase C. Eur. J. Biochem. 210:45-51.
6. Beltz, G. A., and S. J. Flint. 1979. Inhibition of HeLa cell protein synthesis during adenovirus infection: restriction of cellular messenger RNA sequences to the nucleus. J. Mol. Biol. 131:353-373.
7. Blanchette, P., and P. E. Branton. 2009. Manipulation of the ubiquitin-proteasome pathway by small DNA tumor viruses. Virology 384:317-323.
8. Blanchette, P., C. Y. Cheng, Q. Yan, G. Ketner, D. A. Ornelles, T. Dobner, R. C. Conaway, J. W. Conaway, and P. E. Branton. 2004. Both BC-box motifs of adenovirus protein E4orf6 are required to efficiently assemble an E3 ligase complex that degrades p53. Mol. Cell. Biol. 24:9619-9629.
9. Blanchette, P., K. Kindsmuller, P. Groitl, F. Dallaire, T. Speiseder, P. E. Branton, and T. Dobner. 2008. Control of mRNA export by adenovirus E4orf6 and E1B55K proteins during productive infection requires E4orf6 ubiquitin ligase activity. J. Virol. 82:2642-2651. (Pubitemid 351329155)
10. Blum, H., H. Beier, and H. J. Gross. 1987. Improved silver staining of plant proteins, RNA and DNA in polyacrylamide gels. Electrophoresis 8:93-99.
11. Boisvert, F. M., U. Dery, J. Y. Masson, and S. Richard. 2005. Arginine methylation of MRE11 by PRMT1 is required for DNA damage checkpoint control. Genes Dev. 19:671-676.
12. Boisvert, F. M., M. J. Hendzel, J. Y. Masson, and S. Richard. 2005. Methylation of MRE11 regulates its nuclear compartmentalization. Cell Cycle 4:981-989. (Pubitemid 41359766)
13. Boivin, D., M. R. Morrison, R. C. Marcellus, E. Querido, and P. E. Branton. 1999. Analysis of synthesis, stability, phosphorylation, and interacting polypeptides of the 34-kilodalton product of open reading frame 6 of the early region 4 protein of human adenovirus type 5. J. Virol. 73:1245-1253. (Pubitemid 29036778)
14. Cathomen, T., and M. D. Weitzman. 2000. A functional complex of adenovirus proteins E1B-55kDa and E4orf6 is necessary to modulate the expression level of p53 but not its transcriptional activity. J. Virol. 74:11407-11412. (Pubitemid 32224012)
15. Chan, J. Y., T. Y. Hsieh, S. T. Liu, W. Y. Chou, M. H. Chung, and S. M. Huang. 2009. Physical and functional interactions between hnRNP K and PRMT family proteins. FEBS Lett. 583:281-286.
16. Chen, Y., X. Zhou, N. Liu, C. Wang, L. Zhang, W. Mo, and G. Hu. 2008. Arginine methylation of hnRNP K enhances p53 transcriptional activity. FEBS Lett. 582:1761-1765.
17. Cheng, C. Y., P. Blanchette, and P. E. Branton. 2007. The adenovirus E4orf6 E3 ubiquitin ligase complex assembles in a novel fashion. Virology 364:36-44.
18. Cobb, M. H. 1999. MAP kinase pathways. Prog. Biophys. Mol. Biol. 71:479-500.
19. Costanzo, V., K. Robertson, M. Bibikova, E. Kim, D. Grieco, M. Gottesman, D. Carroll, and J. Gautier. 2001. Mre11 protein complex prevents doublestrand break accumulation during chromosomal DNA replication. Mol. Cell 8:137-147. (Pubitemid 32772912)
20. Dallaire, F., P. Blanchette, P. Groitl, T. Dobner, and P. E. Branton. 2009. Identification of integrin alpha3 as a new substrate of the adenovirus E4orf6/ E1B 55-kilodalton E3 ubiquitin ligase complex. J. Virol. 83:5329-5338.
21. Dery, U., Y. Coulombe, A. Rodrigue, A. Stasiak, S. Richard, and J. Y. Masson. 2008. A glycine-arginine domain in control of the human MRE11 DNA repair protein. Mol. Cell. Biol. 28:3058-3069.
22. Dong, Z., Q. Zhong, and P. L. Chen. 1999. The Nijmegen breakage syndrome protein is essential for Mre11 phosphorylation upon DNA damage. J. Biol. Chem. 274:19513-19516.
23. Elliott, J., O. T. Lynch, Y. Suessmuth, P. Qian, C. R. Boyd, J. F. Burrows, R. Buick, N. J. Stevenson, O. Touzelet, M. Gadina, U. F. Power, and J. A. Johnston. 2007. Respiratory syncytial virus NS1 protein degrades STAT2 by using the elongin-cullin E3 ligase. J. Virol. 81:3428-3436. (Pubitemid 46456651)
24. Gatei, M., D. Young, K. M. Cerosaletti, A. Desai-Mehta, K. Spring, S. Kozlov, M. F. Lavin, R. A. Gatti, P. Concannon, and K. Khanna. 2000. ATM-dependent phosphorylation of nibrin in response to radiation exposure. Nat. Genet. 25:115-119.
25. Georgatos, S. D., C. Stournaras, and G. Blobel. 1988. Heterotypic and homotypic associations between the nuclear lamins: site-specificity and control by phosphorylation. Proc. Natl. Acad. Sci. USA 85:4325-4329.
26. Gonzalez, R. A., and S. J. Flint. 2002. Effects of mutations in the adenoviral E1B 55-kilodalton protein coding sequence on viral late mRNA metabolism. J. Virol. 76:4507-4519.
27. Graham, F. L. 1990. Adenoviruses as expression vectors and recombinant vaccines. Trends Biotechnol. 8:85-87. (Pubitemid 20110454)
28. Groitl, P., and T. Dobner. 2007. Construction of adenovirus type 5 early region 1 and 4 virus mutants. Methods Mol. Med. 130:29-39.
29. Halbert, D. N., J. R. Cutt, and T. Shenk. 1985. Adenovirus early region 4 encodes functions required for efficient DNA replication, late gene expression, and host cell shutoff. J. Virol. 56:250-257.
30. Harada, J. N., A. Shevchenko, D. C. Pallas, and A. J. Berk. 2002. Analysis of the adenovirus E1B-55K-anchored proteome reveals its link to ubiquitination machinery. J. Virol. 76:9194-9206.
31. Hartl, B., T. Zeller, P. Blanchette, E. Kremmer, and T. Dobner. 2008. Adenovirus type 5 early region 1B 55-kDa oncoprotein can promote cell transformation by a mechanism independent from blocking p53-activated transcription. Oncogene 27:3673-3684. (Pubitemid 351912972)
32. Howley, P. M., and D. M. Livingston. 2009. Small DNA tumor viruses: large contributors to biomedical sciences. Virology 384:256-259.
33. Huh, K., X. Zhou, H. Hayakawa, J. Y. Cho, T. A. Libermann, J. Jin, J. W. Harper, and K. Munger. 2007. Human papillomavirus type 16 E7 oncoprotein associates with the cullin 2 ubiquitin ligase complex, which contributes to degradation of the retinoblastoma tumor suppressor. J. Virol. 81:9737-9747. (Pubitemid 350067678)
34. Kamura, T., D. Burian, Q. Yan, S. L. Schmidt, W. S. Lane, E. Querido, P. E. Branton, A. Shilatifard, R. C. Conaway, and J. W. Conaway. 2001. Muf1, a novel elongin BC-interacting leucine-rich repeat protein that can assemble with Cul5 and Rbx1 to reconstitute a ubiquitin ligase. J. Biol. Chem. 276: 29748-29753.
35. Kamura, T., K. Maenaka, S. Kotoshiba, M. Matsumoto, D. Kohda, R. C. Conaway, J. W. Conaway, and K. I. Nakayama. 2004. VHL-box and SOCS-box domains determine binding specificity for Cul2-Rbx1 and Cul5-Rbx2 modules of ubiquitin ligases. Genes Dev. 18:3055-3065. (Pubitemid 39658174)
36. Kitten, G. T., and E. A. Nigg. 1991. The CaaX motif is required for isoprenylation, carboxyl methylation, and nuclear membrane association of lamin B2. J. Cell Biol. 113:13-23.
37. Konstantinova, I. M., A. S. Tsimokha, and A. G. Mittenberg. 2008. Role of proteasomes in cellular regulation. Int. Rev. Cell Mol. Biol. 267:59-124.
38. Kyriakis, J. M., H. App, X. F. Zhang, P. Banerjee, D. L. Brautigan, U. R. Rapp, and J. Avruch. 1992. Raf-1 activates MAP kinase-kinase. Nature 358:417-421.
39. Li, T., E. Evdokimov, R. F. Shen, C. C. Chao, E. Tekle, T. Wang, E. R. Stadtman, D. C. Yang, and P. B. Chock. 2004. Sumoylation of heterogeneous nuclear ribonucleoproteins, zinc finger proteins, and nuclear pore complex proteins: a proteomic analysis. Proc. Natl. Acad. Sci. USA 101:8551-8556.
40. Lim, D. S., S. T. Kim, B. Xu, R. S. Maser, J. Lin, J. H. Petrini, and M. B. Kastan. 2000. ATM phosphorylates p95/nbs1 in an S-phase checkpoint pathway. Nature 404:613-617.
41. Luo, K., E. Ehrlich, Z. Xiao, W. Zhang, G. Ketner, and X. F. Yu. 2007. Adenovirus E4orf6 assembles with Cullin5-ElonginB-ElonginC E3 ubiquitin ligase through an HIV/SIV Vif-like BC-box to regulate p53. FASEB J. 21:1742-1750.
42. Mahrour, N., W. B. Redwine, L. Florens, S. K. Swanson, S. Martin-Brown, W. D. Bradford, K. Staehling-Hampton, M. P. Washburn, R. C. Conaway, and J. W. Conaway. 2008. Characterization of cullin-box sequences that direct recruitment of Cul2-Rbx1 and Cul5-Rbx2 modules to elongin BC-based ubiquitin ligases. J. Biol. Chem. 283:8005-8013.
43. Marcellus, R. C., J. G. Teodoro, R. Charbonneau, G. C. Shore, and P. E. Branton. 1996. Expression of p53 in Saos-2 osteosarcoma cells induces apoptosis which can be inhibited by Bcl-2 or the adenovirus E1B-55 kDa protein. Cell Growth Differ. 7:1643-1650.
44. Maxwell, P. H., M. S. Wiesener, G. W. Chang, S. C. Clifford, E. C. Vaux, M. E. Cockman, C. C. Wykoff, C. W. Pugh, E. R. Maher, and P. J. Ratcliffe. 1999. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399:271-275.
45. Mehle, A., J. Goncalves, M. Santa-Marta, M. McPike, and D. Gabuzda. 2004. Phosphorylation of a novel SOCS-box regulates assembly of the HIV-1 Vif-Cul5 complex that promotes APOBEC3G degradation. Genes Dev. 18: 2861-2866. (Pubitemid 39602304)
46. Mittal, R., S. Y. Peak-Chew, and H. T. McMahon. 2006. Acetylation of MEK2 and I κB kinase (IKK) activation loop residues by YopJ inhibits signaling. Proc. Natl. Acad. Sci. USA 103:18574-18579.
47. Moore, M., N. Horikoshi, and T. Shenk. 1996. Oncogenic potential of the adenovirus E4orf6 protein. Proc. Natl. Acad. Sci. USA 93:11295-11301.
48. Nevels, M., S. Rubenwolf, T. Spruss, H. Wolf, and T. Dobner. 2000. Two distinct activities contribute to the oncogenic potential of the adenovirus type 5 E4orf6 protein. J. Virol. 74:5168-5181. (Pubitemid 30313857)
49. Nevels, M., B. Tauber, T. Spruss, H. Wolf, and T. Dobner. 2001. "Hit-and-run" transformation by adenovirus oncogenes. J. Virol. 75:3089-3094.
50. Ostareck-Lederer, A., D. H. Ostareck, C. Cans, G. Neubauer, K. Bomsztyk, G. Superti-Furga, and M. W. Hentze. 2002. c-Src-mediated phosphorylation of hnRNP K drives translational activation of specifically silenced mRNAs. Mol. Cell. Biol. 22:4535-4543.
51. Ostareck-Lederer, A., D. H. Ostareck, K. P. Rucknagel, A. Schierhorn, B. Moritz, S. Huttelmaier, N. Flach, L. Handoko, and E. Wahle. 2006. Asymmetric arginine dimethylation of heterogeneous nuclear ribonucleoprotein K by protein-arginine methyltransferase 1 inhibits its interaction with c-Src. J. Biol. Chem. 281:11115-11125.
52. Ostrowski, J., Y. Kawata, D. S. Schullery, O. N. Denisenko, Y. Higaki, C. K. Abrass, and K. Bomsztyk. 2001. Insulin alters heterogeneous nuclear ribonucleoprotein K protein binding to DNA and RNA. Proc. Natl. Acad. Sci. USA 98:9044-9049.
53. Ostrowski, J., D. S. Schullery, O. N. Denisenko, Y. Higaki, J. Watts, R. Aebersold, L. Stempka, M. Gschwendt, and K. Bomsztyk. 2000. Role of tyrosine phosphorylation in the regulation of the interaction of heterogeneous nuclear ribonucleoprotein K protein with its protein and RNA partners. J. Biol. Chem. 275:3619-3628.
54. Paley, E. L. 1997. A mammalian tryptophanyl-tRNA synthetase is associated with protein kinase activity. Eur. J. Biochem. 244:780-788.
55. Paley, E. L. 1999. Tryptamine-mediated stabilization of tryptophanyl-tRNA synthetase in human cervical carcinoma cell line. Cancer Lett. 137:1-7. (Pubitemid 29179490)
56. Paley, E. L., V. N. Baranov, N. M. Alexandrova, and L. L. Kisselev. 1991. Tryptophanyl-tRNA synthetase in cell lines resistant to tryptophan analogs. Exp. Cell Res. 195:66-78.
57. Paul, S. 2008. Dysfunction of the ubiquitin-proteasome system in multiple disease conditions: therapeutic approaches. Bioessays 30:1172-1184.
58. Pause, A., S. Lee, R. A. Worrell, D. Y. Chen, W. H. Burgess, W. M. Linehan, and R. D. Klausner. 1997. The von Hippel-Lindau tumor-suppressor gene product forms a stable complex with human CUL-2, a member of the Cdc53 family of proteins. Proc. Natl. Acad. Sci. USA 94:2156-2161.
59. Petroski, M. D., and R. J. Deshaies. 2005. Function and regulation of cullin-RING ubiquitin ligases. Nat. Rev. Mol. Cell. Biol. 6:9-20.
60. Pilder, S., M. Moore, J. Logan, and T. Shenk. 1986. The adenovirus E1B-55K transforming polypeptide modulates transport or cytoplasmic stabilization of viral and host cell mRNAs. Mol. Cell. Biol. 6:470-476.
61. Querido, E., P. Blanchette, Q. Yan, T. Kamura, M. Morrison, D. Boivin, W. G. Kaelin, R. C. Conaway, J. W. Conaway, and P. E. Branton. 2001. Degradation of p53 by adenovirus E4orf6 and E1B55K proteins occurs via a novel mechanism involving a cullin-containing complex. Genes Dev. 15: 3104-3117. (Pubitemid 33115675)
62. Querido, E., R. C. Marcellus, A. Lai, R. Charbonneau, J. G. Teodoro, G. Ketner, and P. E. Branton. 1997. Regulation of p53 levels by the E1B 55-kilodalton protein and E4orf6 in adenovirus-infected cells. J. Virol. 71: 3788-3798. (Pubitemid 27172392)
63. Querido, E., M. R. Morrison, H. Chu-Pham-Dang, S. W. Thirlwell, D. Boivin, and P. E. Branton. 2001. Identification of three functions of the adenovirus e4orf6 protein that mediate p53 degradation by the E4orf6-E1B55K complex. J. Virol. 75:699-709. (Pubitemid 32037273)
64. Reich, N. C., P. Sarnow, E. Duprey, and A. J. Levine. 1983. Monoclonal antibodies which recognize native and denatured forms of the adenovirus DNA-binding protein. Virology 128:480-484.
65. Roth, J., C. Konig, S. Wienzek, S. Weigel, S. Ristea, and M. Dobbelstein. 1998. Inactivation of p53 but not p73 by adenovirus type 5 E1B 55-kilodalton and E4 34-kilodalton oncoproteins. J. Virol. 72:8510-8516. (Pubitemid 28471787)
66. Roulston, A., R. C. Marcellus, and P. E. Branton. 1999. Viruses and apoptosis. Annu. Rev. Microbiol. 53:577-628.
67. Runnegar, M. T., X. Wei, and S. F. Hamm-Alvarez. 1999. Increased protein phosphorylation of cytoplasmic dynein results in impaired motor function. Biochem. J. 342(Pt. 1):1-6.
68. Rusinol, A. E., and M. S. Sinensky. 2006. Farnesylated lamins, progeroid syndromes, and farnesyl transferase inhibitors. J. Cell Sci. 119:3265-3272.
69. Sarnow, P., C. A. Sullivan, and A. J. Levine. 1982. A monoclonal antibody detecting the adenovirus type 5-E1b-58Kd tumor antigen: characterization of the E1B-58KD tumor antigen in adenovirus-infected and -transformed cells. Virology 120:510-517. (Pubitemid 12044113)
70. Schroer, T. A. 2004. Dynactin. Annu. Rev. Cell Dev. Biol. 20:759-779.
71. Schullery, D. S., J. Ostrowski, O. N. Denisenko, L. Stempka, M. Shnyreva, H. Suzuki, M. Gschwendt, and K. Bomsztyk. 1999. Regulated interaction of protein kinase Cδ with the heterogeneous nuclear ribonucleoprotein K protein. J. Biol. Chem. 274:15101-15109.
72. Shen, Y., G. Kitzes, J. A. Nye, A. Fattaey, and T. Hermiston. 2001. Analyses of single-amino-acid substitution mutants of adenovirus type 5 E1B-55K protein. J. Virol. 75:4297-4307. (Pubitemid 32410142)
73. Steegenga, W. T., N. Riteco, A. G. Jochemsen, F. J. Fallaux, and J. L. Bos. 1998. The large E1B protein together with the E4orf6 protein target p53 for active degradation in adenovirus-infected cells. Oncogene 16:349-357.
74. Stewart, G. S., J. I. Last, T. Stankovic, N. Haites, A. M. Kidd, P. J. Byrd, and A. M. Taylor. 2001. Residual ataxia telangiectasia mutated protein function in cells from ataxia telangiectasia patients, with 5762ins137 and 7271T→G mutations, showing a less severe phenotype. J. Biol. Chem. 276:30133-30141.
75. Stracker, T. H., C. T. Carson, and M. D. Weitzman. 2002. Adenovirus oncoproteins inactivate the Mre11-Rad50-NBS1 DNA repair complex. Nature 418:348-352.
76. Vaughan, K. T. 2005. Microtubule plus ends, motors, and traffic of Golgi membranes. Biochim. Biophys. Acta 1744:316-324.
77. Vaughan, P. S., J. D. Leszyk, and K. T. Vaughan. 2001. Cytoplasmic dynein intermediate chain phosphorylation regulates binding to dynactin. J. Biol. Chem. 276:26171-26179.
78. Weinberg, D. H., and G. Ketner. 1986. Adenoviral early region 4 is required for efficient viral DNA replication and for late gene expression. J. Virol. 57:833-838.
79. Woo, J. L., and A. J. Berk. 2007. Adenovirus ubiquitin-protein ligase stimulates viral late mRNA nuclear export. J. Virol. 81:575-587.
80. Wu, X., V. Ranganathan, D. S. Weisman, W. F. Heine, D. N. Ciccone, T. B. O'Neill, K. E. Crick, K. A. Pierce, W. S. Lane, G. Rathbun, D. M. Livingston, and D. T. Weaver. 2000. ATM phosphorylation of Nijmegen breakage syndrome protein is required in a DNA damage response. Nature 405:477-482. (Pubitemid 30367426)
81. Yu, X., Y. Yu, B. Liu, K. Luo, W. Kong, P. Mao, and X. F. Yu. 2003. Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex. Science 302:1056-1060.
82. Zhang, X., Z. Yuan, Y. Zhang, S. Yong, A. Salas-Burgos, J. Koomen, N. Olashaw, J. T. Parsons, X. J. Yang, S. R. Dent., T. P. Yao, W. S. Lane, and E. Seto. 2007. HDAC6 modulates cell motility by altering the acetylation level of cortactin. Mol. Cell 27:197-213. (Pubitemid 47058299)
83. Zhang, Y., M. Zhang, H. Dong, S. Yong, X. Li, N. Olashaw, P. A. Kruk, J. Q. Cheng, W. Bai, J. Chen, S. V. Nicosia, and X. Zhang. 2009. Deacetylation of cortactin by SIRT1 promotes cell migration. Oncogene 28:445-460.
84. Zhao, S., Y. C. Weng, S. S. Yuan, Y. T. Lin, H. C. Hsu, S. C. Lin, E. Gerbino, M. H. Song, M. Z. Zdzienicka, R. A. Gatti, J. W. Shay, Y. Ziv, Y. Shiloh, and E. Y. Lee. 2000. Functional link between ataxia-telangiectasia and Nijmegen breakage syndrome gene products. Nature 405:473-477. (Pubitemid 30367425)